Current Value of Holding

$865 Million

Shares

5 Million

% of Portfolio

0.64%

Average Buy Price

$194

Avg closing price
Price range

28 PRIMECAP Management BeiGene Ltd Trades

PRIMECAP Management acquired 5 Million BeiGene Ltd shares worth $865 Million. That's 0.64% of their equity portfolio (41st largest holding). The investor owns 5.28% of the outstanding BeiGene Ltd stock. The first BeiGene Ltd trade was made in Q2 2017. Since then PRIMECAP Management bought shares sixteen more times and sold shares on eleven occasions. The investor's estimated purchase price is $968 Million, resulting in a loss of 11%.

Avg closing price
Price range
Increased shares by 0.3% (+13.2 Thousand shares) Q1 2024
Avg closing price $161.02
Price range $141.80 - $181.47
Sold 0.4% shares (-20.1 Thousand shares) Q4 2023
Avg closing price $180.91
Price range $158.67 - $201.58
Sold 0.1% shares (-5.91 Thousand shares) Q3 2023
Avg closing price $197.87
Price range $179.87 - $225.13
Sold 0.6% shares (-31.3 Thousand shares) Q2 2023
Avg closing price $230.28
Price range $178.30 - $266.78
Sold 0.0% shares (-2.23 Thousand shares) Q1 2023
Avg closing price $239.86
Price range $215.53 - $274.50
Increased shares by 6.6% (+313 Thousand shares) Q4 2022
Avg closing price $183.39
Price range $125.51 - $229.30
Increased shares by 17.5% (+704 Thousand shares) Q3 2022
Avg closing price $171.74
Price range $131.80 - $202.24
Increased shares by 8.7% (+323 Thousand shares) Q2 2022
Avg closing price $156.21
Price range $121.11 - $216.05
Sold 0.2% shares (-8.7 Thousand shares) Q1 2022
Avg closing price $212.59
Price range $146.52 - $269.56
Sold 2.5% shares (-93.8 Thousand shares) Q4 2021
Avg closing price $337.64
Price range $248.56 - $389.34
Sold 1.2% shares (-46.6 Thousand shares) Q3 2021
Avg closing price $326.95
Price range $249.60 - $403.14
Sold 0.8% shares (-30.9 Thousand shares) Q2 2021
Avg closing price $331.23
Price range $292.75 - $367.01
Increased shares by 15.5% (+522 Thousand shares) Q1 2021
Avg closing price $331.14
Price range $260.64 - $382.12
Sold 0.2% shares (-5.56 Thousand shares) Q4 2020
Avg closing price $275.32
Price range $221.31 - $316.61
Increased shares by 92.0% (+1.62 Million shares) Q3 2020
Avg closing price $235.04
Price range $189.18 - $286.44
Increased shares by 3.3% (+56.2 Thousand shares) Q2 2020
Avg closing price $162.77
Price range $123.90 - $195.41
Increased shares by 70.2% (+701 Thousand shares) Q1 2020
Avg closing price $156.39
Price range $121.84 - $173.19
Increased shares by 1.6% (+15.3 Thousand shares) Q4 2019
Avg closing price $166.15
Price range $115.78 - $208.34
Increased shares by 5.9% (+54.4 Thousand shares) Q3 2019
Avg closing price $132.83
Price range $120.61 - $148.29
Increased shares by 0.9% (+8.4 Thousand shares) Q2 2019
Avg closing price $126.92
Price range $113.99 - $146.86

News about BeiGene Ltd - ADR and PRIMECAP Management

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!